secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001193125-25-290679
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics enters $100M ATM offering with Leerink, terminates Jefferies ATM program
--------------------------------------------------------------------------------

- New $100M at-the-market common stock sales agreement with Leerink Partners as agent, dated Nov 21, 2025.
- Agent commission of up to 3.0% of gross sales price per share sold under the agreement.
- Prior $100M Jefferies ATM program terminated effective Nov 21, 2025, with no penalties.
- Shares to be sold via at-the-market or negotiated transactions at company's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/0001193125-25-290679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/d921087d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-290679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer